Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00166179 · ClinicalTrials.gov registry record

Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

A clinical trial of Coronary Artery Disease, sponsored by Emory University.

Completed
Registry status
57
Enrollment target
1
Study location

NCT00166179 is a study of Coronary Artery Disease that has completed, run by Emory University. The registered enrollment target is 57 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00166179, a study of Coronary Artery Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
57 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.

Conditions Studied

Coronary Artery Disease

Study Locations (1)

Georgia

  • Crawford Long Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2003-11
Est. Completion 2006-10

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00166179

The ClinicalTrials.gov registry entry for NCT00166179 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00166179 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00166179 about?

NCT00166179 is a clinical study titled "Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI". The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.

What is the current status of trial NCT00166179?

This trial is currently completed. The enrollment target is 57 participants. The study started on 2003-11. Estimated completion is 2006-10.

What conditions does trial NCT00166179 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT00166179?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00166179 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.